Novo pioneered the modern obesity drug market with Wegovy and Ozempic, but Lilly has rapidly gained market share with Zepbound and Mounjaro, whose active ingredient, tirzepatide, has shown strong clinical results in helping patients lose weight
Readers evaluating GLP-1 peptide education should prioritize measurable endpointsmeal timing, protein intake, GI comfort, and glucose labs when clinically appropriateover dramatic before-and-after galleries
Choosing the right form of BPC157 depends on your goal, experience level, and risk tolerance but if you're seeking true regenerative outcomes, not all forms are created equal
Rapid weight loss typically includes some muscle loss regardless of method
Whether you support or oppose broader peptide access, transparency, thoughtful scientific evaluation, and appropriate regulatory oversight ultimately benefit everyone